Drug Development EXECUTIVE Quotient Sciences: Breaking Down the Silos Between Drug Substance & Drug Product

摘要

Pharma R&D is in its heyday, with funding at record levels. Additionally, thenumber of molecules in the industry pipeline seems to be increasing by about 10%per year on average.